Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
William Patrick “Pat” Leinert, Sr.
Title
Founder, President and CEO, Leinco Technologies, Inc.
Bio
He is responsible for overseeing both companies’ administrative, R&D, sales, and operational activities. Leinco Technologies’ brand is well known in the industry and has become associated with developing, manufacturing, and supplying the highest quality, affordably priced In vivo functional grade recombinant proteins and monoclonal antibodies used in preclinical studies at both academic institutes and biopharmaceutical companies. The company has built the reputation of being the leading supplier of high purity bulk monoclonal antibodies at the gram to kilogram scale and has demonstrated sustained profitability with controlled annual revenue increases of 25%-30%.
Mr. Leinert has 35 years of experience in research, manufacturing, and marketing of early discovery medical research products and active components for medical and veterinary diagnostic tests. He worked as a biochemist in the immunochemical department of Sigma-Aldrich Chemical Company from 1983 - 1988 and was the key person responsible for the scale-up of immunochemical manufacturing. Mr. Leinert also worked as a protein biochemist for Coulter Corporation from 1988 - 1990 in the R&D department of the Immunology Division where he developed purification procedures for proteins used in FDA-approved diagnostic kits.
Mr. Leinert has 35 years of experience in research, manufacturing, and marketing of early discovery medical research products and active components for medical and veterinary diagnostic tests. He worked as a biochemist in the immunochemical department of Sigma-Aldrich Chemical Company from 1983 - 1988 and was the key person responsible for the scale-up of immunochemical manufacturing. Mr. Leinert also worked as a protein biochemist for Coulter Corporation from 1988 - 1990 in the R&D department of the Immunology Division where he developed purification procedures for proteins used in FDA-approved diagnostic kits.
